Evidence map›Paper›PMID 34451962›Full record

ArticleVaccines2021

Evolution and Epidemic Spread of SARS-CoV-2 in Colombia: A Year into the Pandemic.

Sergio Castañeda, Luz H Patiño, Marina Muñoz, Nathalia Ballesteros, Enzo Guerrero-Araya, Daniel Paredes-Sabja, Carolina Flórez, Sergio Gomez, Carolina Ramírez-Santana, Gustavo Salguero and 3 more

Abstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sergio CastañedaCentro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá 111221, Colombia.
Luz H PatiñoCentro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá 111221, Colombia.
Marina MuñozCentro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá 111221, Colombia.ORCID 0000-0002-4216-6928
Nathalia BallesterosCentro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá 111221, Colombia.
Enzo Guerrero-ArayaANID-Millennium Science Initiative Program-Millennium Nucleus in the Biology of the Intestinal Microbiota, Santiago 7510689, Chile.
Daniel Paredes-SabjaANID-Millennium Science Initiative Program-Millennium Nucleus in the Biology of the Intestinal Microbiota, Santiago 7510689, Chile.
Carolina FlórezInstituto Nacional de Salud, Bogotá 111321, Colombia.
Sergio GomezInstituto Nacional de Salud, Bogotá 111321, Colombia.
Carolina Ramírez-SantanaCentro de Estudio de Enfermedades Autoinmunes (CREA), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá 111221, Colombia.
Gustavo SalgueroInstituto Distrital de Ciencia, Biotecnología e Innovación en Salud (IDCBIS), Bogotá 111611, Colombia.ORCID 0000-0002-5018-9927
Juan E GalloGenoma Ces Biotechnologies, Universidad CES, Medellin 050021, Colombia.
Alberto E Paniz-MondolfiIcahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0003-1259-1736
Juan David RamírezCentro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá 111221, Colombia.ORCID 0000-0002-1344-9312

Funding

Scottish Funding Council EP/T003782/1Universidad del Rosario Consiliatura
6 · The paper itself

Abstract

Current efforts to understand the epidemiology, transmission dynamics and emergence of novel SARS-CoV-2 variants worldwide has enabled the scientific community to generate critical information aimed at implementing disease surveillance and control measures, as well as to reduce the social, economic and health impact of the pandemic. Herein, we applied an epidemic model coupled with genomic analysis to assess the SARS-CoV-2 transmission dynamics in Colombia. This epidemic model allowed to identify the geographical distribution,

Indexed as

Colombiaepidemic modelsgenomic surveillanceSARS-CoV-2

Identifiers

PMID34451962
PMCPMC8402472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.